Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

Don’t Ignore Annual PSA Screening

A prostate-specific antigen (PSA) test is the most commonly used tool for screening for prostate cancer. The simple blood test helps to measure the level of PSA in the blood. PSA assists in prostate cancer diagnosis, recurrence, and tracking of treatments like chemotherapy, hormone therapy, radiation, and surgery.

When a patient is treated, their PSA level will significantly drop. If the PSA level rises after treatment, the patient will have what is called biochemical recurrence, which requires additional tests and treatment.

Some years back, doctors had discontinued the annual PSA screening for men who are not at high risk for prostate cancer. This was due to the US Preventive Services Task Force downgrading of the procedure, citing that its harms outweigh patient benefits.

Later on, when the rate of newly diagnosed cases of high-risk prostate cancer began to rise, the USPSTF allowed for PSA screening to reduce deaths from prostate cancer. This goes to show that it recognizes the potential benefit of PSA screening, even if in small margins. It, therefore, recommends that men should discuss their benefits and risks with their doctors and decide whether to get tested or not. 

However, many organizations recommend that men should be educated about prostate cancer to help them understand their options for early detection. They should also have access to the latest screening tests. A PSA test score can help decide how to determine the diagnosis or treatment for prostate cancer.

Due to advanced preventive measures, early detection, and treatment breakthroughs, there has been a drop in prostate cancer death rates. More positive outcomes will be realized if men take the initiative to get screened annually. This could help to detect the disease early, get the right treatment, and save many lives.

PSA screening is still recommended and can be used with other procedures such as multiparametric MRI (mpMRI) before a biopsy.

Annual PSA testing can be carried out after consultation and agreement between doctor and patient. This can help you decide whether mpMRI can help find out what’s causing your PSA levels to rise. It’s better to take the test than ignore and put your prostate health at risk.

More Choice Cancer Care Centers